Fortescue Ltd
FMG
Telstra Group Ltd
TLS
Woodside Energy Group Ltd
WDS
Westpac Banking Corp
WBC
BHP Group Ltd
BHP
AU Stock MarketDetailed Quotes
CYPOA Cynata Therapeutics Ltd
- 0.040
- 0.0000.00%
20min DelayTrading Dec 6 11:15 AET
7.23MMarket Cap0.00P/E (Static)
0.000High0.000Low0Volume0.000Open0.040Pre Close0.00Turnover0.10052wk High0.00%Turnover Ratio180.68MShares0.02252wk Low--EPS TTM5.24MFloat Cap0.100Historical High0.00P/E (Static)131.05MShs Float0.010Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Cynata Therapeutics Ltd Company
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Company Profile
SymbolCYPOA
Company NameCynata Therapeutics Ltd
Founded2003
MarketASX
Employees2
Fiscal Year Ends06-30
Address100 Cubitt Street Level 3
CityCremorne
CountryAustralia
Zip Code3121
Phone+61 370676940
Websitehttps://www.cynata.com
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Kilian Kelly
- Chief Executive Officer,Managing Director
- --
- Geoffrey E.D Brooke
- Non-Executive Director,Non-Executive Chairman
- --
- Paul K Wotton
- Non-Executive Director
- --
- Janine Rolfe
- Non-Executive Director
- --
- Darryl Maher
- Non-Executive Director
- --